Peter Kavsak

Peter Kavsak

McMaster University

H-index: 43

North America-Canada

About Peter Kavsak

Peter Kavsak, With an exceptional h-index of 43 and a recent h-index of 30 (since 2020), a distinguished researcher at McMaster University, specializes in the field of Clinical Biochemistry/Clinical Chemistry.

His recent articles reflect a diverse array of research interests and contributions to the field:

A Canadian survey of perceptions and practices related to ordering of blood tests in the intensive care unit

Discordant High-Sensitivity Cardiac Troponin I Concentrations in the General Population

The clinical chemistry score (CCS) achieves the highest efficacy when assessed with the 99% sensitivity benchmark for myocardial infarction.

Imprecision of high-sensitivity cardiac troponin assays at the female 99th-percentile

High-Sensitivity Cardiac Troponin I for Long-Term Cardiovascular Risk Stratification in a Cancer Clinic Population

High-Sensitivity Cardiac Troponin and the Management of Congenital Heart Disease in Newborns and Infants

Growth differentiation factor 15 (GDF15) predicts relapse free and overall survival in unresected Locally Advanced Non-Small Cell Lung Cancer treated with chemo-radiotherapy.

Individual risk prediction of high grade prostate cancer based on the combination between total prostate-specific antigen (PSA) and free to total PSA ratio

Peter Kavsak Information

University

Position

ECRI HHS HRLMP

Citations(all)

11546

Citations(since 2020)

5278

Cited By

9289

hIndex(all)

43

hIndex(since 2020)

30

i10Index(all)

137

i10Index(since 2020)

96

Email

University Profile Page

Google Scholar

Peter Kavsak Skills & Research Interests

Clinical Biochemistry/Clinical Chemistry

Top articles of Peter Kavsak

A Canadian survey of perceptions and practices related to ordering of blood tests in the intensive care unit

Canadian Journal of Anesthesia/Journal canadien d'anesthésie

2024/3/19

Discordant High-Sensitivity Cardiac Troponin I Concentrations in the General Population

Clinical Chemistry

2024/3

The clinical chemistry score (CCS) achieves the highest efficacy when assessed with the 99% sensitivity benchmark for myocardial infarction.

International Journal of Cardiology

2024/2/20

Imprecision of high-sensitivity cardiac troponin assays at the female 99th-percentile

Clinical Biochemistry

2024/2/13

High-Sensitivity Cardiac Troponin I for Long-Term Cardiovascular Risk Stratification in a Cancer Clinic Population

Cardio Oncology

2024/1/16

High-Sensitivity Cardiac Troponin and the Management of Congenital Heart Disease in Newborns and Infants

2024/1/5

Mario Plebani
Mario Plebani

H-Index: 68

Peter Kavsak
Peter Kavsak

H-Index: 30

Growth differentiation factor 15 (GDF15) predicts relapse free and overall survival in unresected Locally Advanced Non-Small Cell Lung Cancer treated with chemo-radiotherapy.

2024/4/24

Individual risk prediction of high grade prostate cancer based on the combination between total prostate-specific antigen (PSA) and free to total PSA ratio

Clinical Chemistry and Laboratory Medicine (CCLM)

2023/6/27

Reference intervals for thyroid biomarkers to enhance the assessment of thyroid status in childhood and adolescence

Clinical Chemistry and Laboratory Medicine (CCLM)

2023/6/27

Using logistic regression models to investigate the effects of high-sensitivity cardiac troponin T confounders on ruling in acute myocardial infarction

Clinical Chemistry and Laboratory Medicine (CCLM)

2023/6/27

Lot-to-lot bias for high-sensitivity cardiac troponin I concentrations≥ 1000 ng/L

Clinical Chemistry and Laboratory Medicine (CCLM)

2023/6/27

An interference yielding divergent high-sensitivity cardiac troponin results on different instruments from the same manufacturer.

Clinica Chimica Acta; International Journal of Clinical Chemistry

2023/6/20

Association of preoperative growth differentiation factor-15 concentrations and postoperative cardiovascular events after major noncardiac surgery

Anesthesiology

2023/5/1

High-sensitivity troponin i predicts major cardiovascular events after non-cardiac surgery: a vascular events in non-cardiac surgery patients cohort evaluation (VISION) Substudy

Clinical chemistry

2023/5/1

Storage conditions, sample integrity, interferences, and a decision tool for investigating unusual high-sensitivity cardiac troponin results

2023/5/1

ESAIC focused guideline for the use of cardiac biomarkers in perioperative risk evaluation

European Journal of Anaesthesiology| EJA

2023/12/1

Cardiac troponin testing in cardiac surgery

2023/11/2

Identifying very-low-risk patients for future myocardial infarction or death

The Canadian journal of cardiology

2023/4

30-DAY AND 1-YEAR MORTALITY IN A 4-YEAR POPULATION-BASED COHORT: ASSOCIATIONS WITH NATRIURETIC PEPTIDE TYPE AND PREVIOUS HEART FAILURE DIAGNOSIS

Journal of the American College of Cardiology

2023/3/7

Trends in B-Type Natriuretic Peptide Testing: A Population-Based Cohort Study

Heart Failure

2023/11/1

See List of Professors in Peter Kavsak University(McMaster University)